Irritable Bowel Syndrome With Constipation
27
3
3
18
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
14 trials with published results (52%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
7.4%
2 terminated out of 27 trials
90.0%
+3.5% vs benchmark
26%
7 trials in Phase 3/4
78%
14 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (27)
Electro-acupuncture for Irritable Bowel Syndrome With Constipation
A Study of Virtual Reality and Linaclotide for IBS-C
Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)
Home Transcutaneous Electrical Acustimulation (TEA)
Effect of Consuming a Nutraceutical Composition on Signs and Symptoms in Adult Patients With Irritable Bowel Syndrome
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
IBS-C Questionnaire Study
A Multistrain Probiotic in Patients With Irritable Bowel Syndrome With Predominant Constipation
Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations
Personalized Dietary Intervention Based on Microbiome Analysis vs FODMAP Diet for Irritable Bowel Syndrome
Effect of Tai Chi as Treatment for IBS-C
Efficacy and Safety of SYN-010 in IBS-C
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
An Evaluation of Cultured Milk Drink on Immune Status of Patients With Irritable Bowel Syndrome: Constipation Predominant
Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel Syndrome
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation